Infertility Services

Infertility Services Market Outlook

The global infertility services market was valued at approximately USD 24 billion in 2023 and is projected to reach USD 40 billion by 2035, growing at a CAGR of around 5.3% during the forecast period. This growth can be attributed to several factors, including the rising prevalence of infertility due to lifestyle changes, increased awareness and acceptance of fertility treatments, and advancements in reproductive technologies that enhance success rates. Additionally, the growing number of fertility clinics and increased health insurance coverage for infertility treatments are further propelling the market's expansion. Furthermore, the trend of delaying parenthood among couples in developed regions is significant, thereby increasing the demand for infertility services.

Growth Factor of the Market

Several key factors are driving the growth of the infertility services market. Firstly, the increasing incidence of infertility, particularly among couples in developed nations, is a significant contributor. Rising stress levels, changing lifestyle choices, and delayed childbearing are contributing to this trend. Secondly, advancements in assisted reproductive technologies (ART), such as in vitro fertilization (IVF), have improved the success rates of infertility treatment, making it more appealing for couples facing difficulties in conception. Thirdly, the societal acceptance of fertility treatments has grown, reducing the stigma associated with seeking help for infertility issues. Furthermore, the expansion of healthcare infrastructure and the proliferation of specialized fertility clinics have made these services more accessible to a broader population. Lastly, government initiatives promoting awareness and funding for infertility treatments are also boosting market growth.

Key Highlights of the Market

• The global infertility services market is projected to reach USD 40 billion by 2035.
• Assisted reproductive technology remains the leading service type in the infertility services market.
• North America is the largest regional market, accounting for a significant share of the total market revenue.
• IVF procedures are expected to dominate the procedure type segment due to their high success rates.
• There is a notable increase in the number of fertility clinics and research institutes focusing on infertility solutions.

By Service Type

Assisted Reproductive Technology:

Assisted reproductive technology (ART) encompasses a variety of procedures aimed at addressing infertility issues. The most common form of ART is in vitro fertilization (IVF), a complex process where eggs are extracted from a woman's ovaries and fertilized by sperm in a laboratory setting. The resulting embryos are then transferred to the uterus with the goal of achieving a successful pregnancy. As technology advances, ART continues to evolve, with techniques such as intracytoplasmic sperm injection (ICSI) and preimplantation genetic testing becoming more prevalent. The growing success rates associated with these technologies, along with increasing awareness among couples about their infertility options, have led to a significant uptick in ART utilization.

Fertility Drugs:

Fertility drugs play a crucial role in the infertility services market, as they are often the first line of treatment for couples experiencing difficulty conceiving. These medications work by stimulating the ovaries to produce multiple eggs or regulating the hormonal cycle to enhance fertility. Commonly prescribed fertility drugs include clomiphene citrate and gonadotropins, which have shown significant success in treating various types of infertility. The growing acceptance of medication-based treatments, bolstered by ongoing research and development of new pharmaceutical options, is anticipated to fuel the growth of this segment in the coming years. Additionally, the increasing prevalence of infertility conditions such as polycystic ovary syndrome (PCOS) is expected to drive demand for fertility drugs.

Surgical Procedures:

Surgical procedures are a vital component of the infertility services market, particularly for individuals with anatomical abnormalities or conditions that hinder conception. Procedures such as laparoscopic surgery can treat endometriosis, fibroids, and other issues that may affect fertility. These minimally invasive techniques not only improve the chances of conception but also enhance overall reproductive health. The rising number of procedures performed as a result of increased awareness about reproductive health issues and the availability of advanced surgical techniques are anticipated to contribute to the growth of this segment. Moreover, surgical interventions can be complementary to ART, further integrating the two approaches in the treatment of infertility.

Diagnostic Testing:

Diagnostic testing is essential for identifying the underlying causes of infertility. It typically involves a series of tests and evaluations, including hormonal assessments, imaging studies, and semen analyses, to determine the most effective course of treatment. As couples increasingly seek personalized care, the demand for accurate and comprehensive diagnostic testing has risen, leading to advancements in methodologies and technologies used for these evaluations. The growing emphasis on early diagnosis and tailored treatment plans is expected to enhance the efficacy of infertility services and promote better patient outcomes. This segment is likely to see sustained growth as healthcare providers continue to invest in state-of-the-art diagnostic tools and techniques.

Others:

Other services in the infertility market include counseling, lifestyle modification programs, and alternative therapies, such as acupuncture and herbal medicine. These options cater to individuals who may be seeking additional support alongside conventional treatments. The holistic approach to infertility treatment, which considers emotional well-being and lifestyle factors, is gaining traction among patients. Moreover, the integration of complementary therapies alongside ART and medical interventions can enhance treatment efficacy and improve overall patient satisfaction. As more individuals look for comprehensive care that addresses both physical and emotional aspects of infertility, the 'Others' segment is expected to experience growth alongside traditional treatment modalities.

By End User

Hospitals:

Hospitals serve as a primary setting for delivering infertility services, offering a wide range of treatments and procedures. Many hospitals have specialized reproductive health departments equipped with advanced technologies and skilled professionals to provide comprehensive care for infertility patients. The advantage of hospitals lies in their integrated healthcare services, which can include surgical procedures, diagnostic testing, and emergency care if needed. With the growing demand for infertility treatments, many hospitals are expanding their reproductive health services to accommodate the needs of couples seeking assistance in conception. This trend is expected to support the growth of the infertility services market significantly.

Fertility Clinics:

Fertility clinics are specialized entities that focus solely on the evaluation and treatment of infertility. These clinics provide a comprehensive range of infertility services, including ART, fertility drugs, and diagnostic testing, often in a more personalized and focused environment compared to hospitals. The emergence of numerous fertility clinics has made infertility services more accessible to couples, particularly in urban areas. As advances in technology continue to improve success rates, fertility clinics are expected to see an increase in patient volume. Their ability to offer tailored treatment plans and emotional support to patients also positions them as a popular choice among couples seeking assistance with fertility challenges.

Research Institutes:

Research institutes play a crucial role in the advancement of infertility services through clinical research and development of new technologies and treatment protocols. These institutions are involved in exploring innovative methods to enhance infertility treatment outcomes, such as genetic testing and advanced reproductive techniques. The collaboration between research institutes and fertility clinics often leads to the implementation of cutting-edge solutions in clinical practice. Furthermore, research activities can contribute to increased awareness and understanding of infertility issues, ultimately encouraging couples to seek treatment. As the demand for more effective infertility solutions rises, research institutes will continue to be vital players in the market.

Others:

This category encompasses various alternative providers of infertility services, including wellness centers, holistic practitioners, and support groups. These entities often focus on the emotional and psychological aspects of infertility, offering counseling, support programs, and lifestyle coaching to couples experiencing infertility challenges. While these services may not directly provide medical interventions, they play a significant role in the overall treatment process by addressing the emotional well-being of patients. As awareness of the importance of mental health in infertility treatment increases, the demand for alternative and supplementary services is expected to grow, contributing positively to the infertility services market.

By Procedure Type

In Vitro Fertilization:

In vitro fertilization (IVF) is the most widely recognized and utilized procedure within the infertility services market. This complex process involves stimulating the ovaries to produce multiple eggs, retrieving those eggs, and fertilizing them with sperm outside the body in a laboratory setting. IVF has become a preferred choice for many couples due to its relatively high success rates compared to other infertility treatments. The increasing efficacy of IVF, coupled with advancements in techniques such as preimplantation genetic testing (PGT) and embryo freezing, has made it a cornerstone of assisted reproductive technology. As more couples seek effective solutions for infertility challenges, the demand for IVF procedures is expected to remain strong, driving growth in this segment.

Artificial Insemination:

Artificial insemination, including intrauterine insemination (IUI), is a less invasive fertility treatment option that involves placing sperm directly into a woman's uterus during her ovulation period. This procedure is commonly recommended for couples with mild infertility issues or unexplained infertility. The simplicity and lower cost associated with artificial insemination make it an attractive option for many couples, contributing to its steady demand in the market. Furthermore, advancements in sperm processing and the use of donor sperm have enhanced the success rates of artificial insemination, making it a viable alternative to more invasive procedures. As awareness of fertility treatment options continues to expand, the artificial insemination segment is expected to show significant growth.

Surrogacy:

Surrogacy is an increasingly recognized option for couples unable to conceive due to medical or personal circumstances. This process involves a surrogate mother carrying and delivering a child for intended parents. Surrogacy can be particularly appealing to same-sex couples and individuals with medical conditions that prevent them from carrying a pregnancy to term. The growth of surrogacy services is driven by changing societal norms regarding family structures and the increasing acceptance of assisted reproductive techniques. As legal frameworks concerning surrogacy evolve and more agencies offer support and guidance, this segment is anticipated to grow, providing a crucial pathway to parenthood for many couples.

Egg Freezing:

Egg freezing, or oocyte cryopreservation, is a growing trend in fertility services, allowing women to preserve their eggs for future use. This procedure is particularly appealing to women who wish to delay childbirth for personal, professional, or health-related reasons. Egg freezing offers the advantage of enabling women to maintain their fertility even as their biological clock advances. The increasing awareness of this option, coupled with advancements in freezing technologies that have improved success rates, is expected to drive the demand for egg freezing services. As more women consider this proactive approach to fertility, the egg freezing segment is poised for significant growth in the coming years.

Others:

Other procedures in the infertility services market include gamete intrafallopian transfer (GIFT) and zygote intrafallopian transfer (ZIFT). These less common assisted reproductive technologies involve placing fertilized or unfertilized eggs directly into the fallopian tubes. Although they are not as frequently performed as IVF, they provide additional options for specific infertility cases, particularly for couples with certain medical conditions. The availability of alternative procedures enhances the flexibility and choices available to individuals seeking infertility treatments. As more patients become informed about their options, the demand for these alternative procedures may rise, contributing to the overall growth of the infertility services market.

By Geography

North America:

North America holds a significant share of the global infertility services market, driven by advanced healthcare infrastructure, high per capita healthcare expenditure, and widespread awareness of fertility treatments. The United States, in particular, is a leader in the adoption of assisted reproductive technologies, with a substantial number of fertility clinics and specialists available to provide comprehensive services. The market is further supported by favorable regulations, insurance coverage for certain infertility treatments, and the presence of numerous research institutes focused on reproductive health. With a projected CAGR of around 5.4% during the forecast period, North America is expected to maintain its dominance in the global infertility services market.

Europe:

Europe represents a robust market for infertility services, characterized by diverse regulations and varying levels of accessibility to fertility treatments across different countries. The United Kingdom, Germany, and France are among the leading countries in Europe, where advances in reproductive technology and increasing public awareness are driving market growth. The European Society of Human Reproduction and Embryology (ESHRE) plays a pivotal role in promoting best practices and guidelines for assisted reproductive technologies across the continent. Moreover, the ongoing research and development efforts in reproductive health are expected to contribute to the growth of the infertility services market in Europe, with a projected CAGR of approximately 5.1% over the forecast period.

Asia Pacific:

The Asia Pacific region is witnessing rapid growth in the infertility services market, fueled by a combination of increasing infertility rates, rising disposable incomes, and greater awareness of reproductive health issues. Countries such as India, China, and Australia are emerging as significant players in this market, with a growing number of fertility clinics and ART facilities available to cater to the increasing demand. The cultural shift towards accepting infertility treatments and the proliferation of medical tourism for fertility services in countries like India are further propelling market growth. The Asia Pacific region is expected to experience a CAGR of around 6.2% during the forecast period, making it one of the fastest-growing markets for infertility services globally.

Latin America:

Latin America presents a developing market for infertility services, characterized by a rising awareness of infertility treatments and a growing number of fertility clinics across the region. Brazil and Mexico are at the forefront of this growth, offering a variety of ART options and establishing themselves as attractive destinations for medical tourism. The increasing prevalence of infertility conditions, along with evolving social norms regarding family planning and reproductive health, are expected to drive demand for infertility services in Latin America. As healthcare access improves and government initiatives are implemented to promote reproductive health, the Latin American market is anticipated to grow steadily, with a projected CAGR of approximately 4.5% during the forecast period.

Middle East & Africa:

The Middle East and Africa region is gradually emerging in the infertility services market, supported by increasing awareness and advancements in healthcare infrastructure. Countries such as Israel, the United Arab Emirates, and South Africa are witnessing growing investments in fertility clinics and ART services. Cultural attitudes towards infertility are evolving, leading to increased acceptance of treatments, particularly among younger generations. The rising prevalence of lifestyle-related infertility issues and improved healthcare access are also contributing to market growth in this region. Although the Middle East and Africa are expected to experience slower growth compared to other regions, a CAGR of around 4.2% is projected, indicating a gradual but notable increase in demand for infertility services.

Opportunities

The infertility services market presents a plethora of opportunities for growth and innovation, particularly through advancements in technology and the increasing acceptance of treatment options. One of the most significant opportunities is the ongoing research and development in reproductive technologies, including the enhancement of ART techniques, genetic testing, and embryo selection processes. As these technologies improve, they are likely to increase the success rates of procedures like in vitro fertilization, thereby attracting more couples to seek treatment. Additionally, the emergence of telemedicine and online consultation services offers a novel avenue for fertility specialists to reach a broader patient base, particularly those in remote areas. The integration of holistic approaches, combining physical and mental health strategies, also opens doors for innovative service offerings tailored to the emotional needs of patients undergoing infertility treatments.

Furthermore, as societal norms continue to shift, there is a growing demand for alternative family-building options, such as surrogacy and egg freezing. Ice breaking discussions surrounding fertility preservation for women of advanced maternal age and those pursuing careers are gaining traction. This trend is leading to an increasing number of fertility preservation services and awareness campaigns that educate the population about these options. Government initiatives aimed at providing better access to fertility treatments and insurance coverage for infertility services also present substantial opportunities for market growth. The combination of these factors, along with the rise in global infertility rates, suggests that the infertility services market is well-positioned for continued expansion in the coming years.

Threats

The infertility services market faces various threats that could impact its growth trajectory. One of the most significant challenges is the high cost associated with many infertility treatments, particularly assisted reproductive technologies like in vitro fertilization. The financial burden can deter couples from seeking necessary treatments, leading to lower market penetration, especially in regions where healthcare coverage for infertility services is limited. Furthermore, the variable success rates of different treatments can lead to patient dissatisfaction and reluctance to pursue further interventions, contributing to a negative perception of infertility services. Additionally, the regulatory environment surrounding infertility treatments varies widely across countries, leading to inconsistencies in service availability and quality. These disparities can create challenges for global providers seeking to offer uniform services across different markets.

Moreover, the stigma associated with infertility and reproductive health issues may continue to hinder individuals from seeking help. In certain cultures, discussing fertility struggles remains taboo, and this societal pressure may prevent couples from exploring treatment options. Lastly, as the market for infertility services expands, increased competition among service providers could lead to challenges regarding differentiation and quality of service. In a rapidly evolving landscape, providers must continually invest in innovative solutions and marketing strategies to stand out. These threats, if not adequately addressed, could impede the growth of the infertility services market and limit access for couples seeking assistance with infertility challenges.

Competitor Outlook

• IVF Australia
• Fertility Centers of Illinois
• California Cryobank
• CCRM Fertility
• New Hope Fertility Center
• Shady Grove Fertility
• Reproductive Health Specialists
• Bourn Hall Clinic
• Genea
• Fertility and IVF Center
• Boston IVF
• Reproductive Medicine Institute
• Centre for Reproductive Medicine
• Oregon Reproductive Medicine
• Northwestern Medicine

The competitive landscape of the infertility services market is characterized by a diverse array of providers, ranging from specialized fertility clinics to large healthcare systems that offer reproductive health services. These competitors vary in terms of the scale of their operations, the range of services offered, and their geographic presence. As the demand for infertility treatments continues to rise, many companies are investing in advanced technologies, such as artificial intelligence and genetic testing, to enhance their service offerings and improve patient outcomes. Additionally, providers are increasingly focusing on building strong brand identities and patient relationships through comprehensive marketing strategies and community outreach programs. This competitive environment encourages innovation and quality improvements, ultimately benefiting couples seeking infertility treatments.

Key players in the infertility services market include IVF Australia, known for its extensive network of clinics and a strong emphasis on patient care and support. Fertility Centers of Illinois has established itself as a leader in the Midwest, offering a broad range of ART services and cutting-edge technologies to enhance treatment success rates. CCRM Fertility has gained recognition for its personalized care approach and comprehensive fertility assessments, catering to the specific needs of patients. Another prominent player, Shady Grove Fertility, has a strong presence in the United States, providing a wide array of infertility treatments along with financial support options to help patients navigate costs. Organizations like Bourn Hall Clinic and Genea are also making significant strides in the reproductive health sector, offering innovative solutions and maintaining a patient-centered focus.

As the infertility services market progresses, it will be essential for these companies to adapt to evolving patient needs and the competitive landscape. Emphasis on research and development will be crucial to keep up with advancements in reproductive medicine. Companies may need to pursue strategic partnerships and collaborations with research institutions to stay at the forefront of innovation. Furthermore, expanding service offerings to include holistic approaches and emotional support services will be vital as patients increasingly seek comprehensive care. The ability to provide a seamless patient experience, from initial consultation to post-treatment support, will differentiate successful providers in this growing market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Genea
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Boston IVF
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 IVF Australia
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 CCRM Fertility
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Bourn Hall Clinic
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 California Cryobank
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Northwestern Medicine
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Shady Grove Fertility
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Fertility and IVF Center
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 New Hope Fertility Center
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Oregon Reproductive Medicine
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Fertility Centers of Illinois
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Reproductive Health Specialists
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Reproductive Medicine Institute
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Centre for Reproductive Medicine
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Infertility Services Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Fertility Clinics
    • 6.1.3 Research Institutes
    • 6.1.4 Others
  • 6.2 Infertility Services Market, By Geography
    • 6.2.1 North America
    • 6.2.2 Europe
    • 6.2.3 Asia Pacific
    • 6.2.4 Latin America
    • 6.2.5 Middle East & Africa
  • 6.3 Infertility Services Market, By Service Type
    • 6.3.1 Assisted Reproductive Technology
    • 6.3.2 Fertility Drugs
    • 6.3.3 Surgical Procedures
    • 6.3.4 Diagnostic Testing
    • 6.3.5 Others
  • 6.4 Infertility Services Market, By Procedure Type
    • 6.4.1 In Vitro Fertilization
    • 6.4.2 Artificial Insemination
    • 6.4.3 Surrogacy
    • 6.4.4 Egg Freezing
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Infertility Services Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Infertility Services market is categorized based on

By Service Type

• Assisted Reproductive Technology
• Fertility Drugs
• Surgical Procedures
• Diagnostic Testing
• Others

By End User

• Hospitals
• Fertility Clinics
• Research Institutes
• Others

By Procedure Type

• In Vitro Fertilization
• Artificial Insemination
• Surrogacy
• Egg Freezing
• Others

By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• IVF Australia
• Fertility Centers of Illinois
• California Cryobank
• CCRM Fertility
• New Hope Fertility Center
• Shady Grove Fertility
• Reproductive Health Specialists
• Bourn Hall Clinic
• Genea
• Fertility and IVF Center
• Boston IVF
• Reproductive Medicine Institute
• Centre for Reproductive Medicine
• Oregon Reproductive Medicine
• Northwestern Medicine